Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BioTime and Organon Teknika establish exclusive license agreement for Hextend

Feb. 19, 2001

Long-acting contraceptive launched by Berlex in U.S.

Feb. 16, 2001

Series of international patents issued to Bayer for new agents for anemia

Feb. 15, 2001

New agents for osteoporosis act by inhibiting osteoclast vacuolar ATPase

Feb. 15, 2001

Potential new agent for reducing NIDDM-associated hyperglycemia without side effects

Feb. 14, 2001

Mochida describes new series with potent cholesterol-lowering effects

Feb. 14, 2001

Novel imidazolines only stimulate insulin release during hyperglycemia

Feb. 14, 2001

Potent PPAR agonists and their use presented by Merck & Co.

Feb. 14, 2001

SkyePharma to manufacture NK-104 for Kowa

Feb. 13, 2001

Starlix launched in U.S. for type 2 diabetes

Feb. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...